A

Atara Biotherapeutics
D

ATRA

8.47000
USD
-0.25
(-2.87%)
مفتوح الان
حجم التداول
712
الربح لكل سهم
3
العائد الربحي
-
P/E
-4
حجم السوق
50,492,982
أصول ذات صلة
C
CRVS
0.04500
(1.08%)
4.22500 USD
F
FATE
-0.02000
(-1.57%)
1.25000 USD
R
RCKT
-0.05500
(-1.87%)
2.88000 USD
R
RGEN
-4.740
(-3.72%)
122.790 USD
T
TXG
0.380
(3.65%)
10.800 USD
V
VKTX
0.700
(2.69%)
26.770 USD
المزيد
الأخبار المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).